Abstract
98 patients of all age groups were treated with the new broad-spectrum penicillin, amoxycillin (BRL 2333), for infections of the upper and lower respiratory tract, the urinary tract, otitis media and biliary tract infections. The product had to be discontinued in 5 cases because of side-effects; in 83 cases, there was a complete clinical resolution; and in 10 cases, there was a symptomatic improvement. Amoxycillin has showed its value as a routine antibiotic for the treatment ofbacterial infections in general practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
